The goal of this clinical trial is to learn if a computer software program (cardiac simulator) for surgical planning will lead to improvements in patient care by decreasing the incidence of unsuccessful interventions and reinterventions for pediatric patients with congenital heart disease. It is not a commercially available device to treat congenital heart disease in pediatric patients. The main aims are: To provide safe pre-operative testing of surgical approaches with a computer model cardiac simulator. To aid surgeons in envisioning different surgical approaches for each individual patient. To bolster the standard of care surgical planning discussions which will be particularly useful for patients with unique, complex congenital heart disease. Participants will: Consent to being randomized with a 50% chance of receiving standard of care "on the fly" surgical planning discussion as is current practice or assisted surgical planning discussion with the aid of the computer software cardiac simulator. Receive results of their computer simulated findings during their surgical planning discussion if they are in the cardiac simulator group.
The computer software will be developed at the Cardiovascular Biomechanics Computation Lab at Stanford.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
275
A computer software cardiac simulator for surgical planning in complex Congenital Heart Disease (CHD) pediatric patients.
Mortality
Alive or deceased post-operative
Time frame: At date of hospital discharge or up to 30 days post-operation
Mortality
Alive or deceased long-term
Time frame: Latest follow-up exam up to 3 years post-operation
Number of cardioplegic arrest
Due to quality of pathways to blood flow, function of inlet and outlet valves, or residual hemodynamic lesions during operation (up to 5 times)
Time frame: Up to 10 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.